Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
There is a possibility that gut microbiota modifiers could positively impact Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD), yet there is a shortage of randomized controlled trials (RCT) involving children (1)
A double-blind randomized clinical supportive care trial evaluating VSL#3 TM vs. placebo in 48 randomized obese children with biopsy-proven [Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)](brain://0_T4lKylP0CsXkdsY4SiLw/NonAlcoholicFattyLiverDiseaseNafldMetabolicD…